Affiliation:
1. Department of Ophthalmology, Medical College of Wisconsin, Milwaukee 53226.
Abstract
A double-masked, placebo-controlled, randomized study was done to assess the safety and clinical and quantitative microbiologic efficacy of 1% mercuric oxide (yellow) ophthalmic ointment in the treatment of eyelid infections, i.e., bacterial blepharitis. A total of 39 patients with bacterial counts and clinical signs indicative of eyelid infection were treated twice daily for 7 days. Clinical biomicroscopic examination and quantitative microbiologic cultures were done just prior to initiation of treatment and again on days 3 and 7. Statistical analysis revealed a significant improvement in the clinical signs, bacterial count, cure rate, and improvement rate for subjects taking the active medication, compared with those taking the placebo on days 3 and 7. In addition, the medication was well tolerated.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference20 articles.
1. Experimental production of conjunctivitis with staphylococci;Allen J. H.;Am. J. Ophthalmol.,1939
2. Comparative bacteriology of chronic blepharitis;Dougherty J. M.;Br. J. Ophthalmol.,1984
3. Bacterial lipases and chronic blepharitis;Dougherty J. M.;Invest. Ophthalmol. Visual Sci.,1986
4. Duke-Elder S. and P. A. MacFaul. 1974. The ocular adnexa. I. Diseases of the eyelid p. 205-225. In S. Duke-Elder (ed.) System of ophthalmology vol. 13. C. V. Mosby Co. St. Louis.
5. Gilman A. G. L. S. Goodman and A. Gilman (ed.). 1980. Goodman & Gilman's the pharmacologic basis of therapeutics 6th ed. MacMillan Publishing Co. New York.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献